The use of biorelevant dissolution media to forecast the in vivo performance of a drug.
Simulation of gastrointestinal conditions is essential to adequately predict the in vivo behavior of drug formulations. To reduce the size and number of human studies required to identify a drug product with appropriate performance in both the fed and fasted states, it is advantageous to be able to pre-screen formulations in vitro. The choice of appropriate media for such in vitro tests is crucial to their ability to correctly forecast the food effect in pharmacokinetic studies. The present paper gives an overview of the development and composition of biorelevant dissolution media that can be used for the in vitro simulation of different dosing conditions (fasted and fed states). In addition, the application of these media to predicting food effects is described in several case examples.
Klein
Sandra
S
Institute of Pharmacy, Biopharmacy and Pharmaceutical Technology, Ernst Moritz Arndt University, 17 Friedrich Ludwig Jahn Street, Greifswald 17489, Germany. Sandra.Klein@uni-greifswald.de
D018565:Food-Drug Interactions; D010599:Pharmacokinetics; D010600:Pharmacology; D012995:Solubility
Eur J Pharm Sci. 2005 Mar;24(4):297-303
15734296
Wien Med Wochenschr. 1981 Mar 15;131(5):127-32
7233908
Eur J Clin Pharmacol. 1979 May 21;15(4):269-74
477711
Int J Pharm. 2001 Jan 5;212(1):81-91
11165823
Pharm Res. 1995 Mar;12(3):413-20
7617530
J Clin Pharmacol. 1993 Apr;33(4):381-6
8473554
Nat Rev Drug Discov. 2007 Mar;6(3):231-48
17330072
Pharm Res. 2008 Jul;25(7):1663-76
18404251
Arch Intern Med. 1972 Oct;130(4):506-27
4562149
Annu Rev Med. 1967;18:333-76
5337530
Pharm Res. 1990 Jul;7(7):756-61
2395805
Methods Find Exp Clin Pharmacol. 2004 Oct;26(8):634-8
15605125
Eur J Pharm Biopharm. 2004 Sep;58(2):265-78
15296954
Pharm Res. 2007 May;24(5):909-17
17372688
Pharm Res. 1988 May;5(5):272-82
3244637
Pharm Res. 1999 Dec;16(12):1871-5
10644076
Eur J Drug Metab Pharmacokinet. 1998 Apr-Jun;23(2):97-102
9725464
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):75-87
11259834
Am J Dig Dis. 1966 Jul;11(7):503-21
5937767
Arch Intern Med. 1972 Oct;130(4):618-30
4629238
Eur J Pharm Biopharm. 2005 Aug;60(3):413-7
15893920
Pharm Res. 1998 Jan;15(1):11-22
9487541
Eur J Pharm Sci. 2000 Oct;11 Suppl 2:S73-80
11033429
J Pharm Sci. 1968 Aug;57(8):1322-6
5677333
Chem Pharm Bull (Tokyo). 1980 Aug;28(8):2443-9
7428127
J Pharm Sci. 2007 Nov;96(11):3100-16
17712849
Eur J Pharm Sci. 2007 Aug;31(5):249-61
17616376
Pharm Res. 1998 May;15(5):698-705
9619777
J Pharm Pharmacol. 2004 May;56(5):605-10
15142337
J Clin Pharm Ther. 2001 Jun;26(3):159-69
11422598
AAPS PharmSciTech. 2008;9(4):1179-84
19034672
Dig Dis Sci. 1987 May;32(5):472-80
3646103
Pharm Res. 2006 Jan;23(1):165-76
16308672
Pharm Res. 1991 Dec;8(12):1461-9
1808607
Pharm Res. 1993 Feb;10(2):187-96
8456064